An experimental new drug could be more effective than existing drugs against swine flu and bird flu, a UW-Madison researcher found. The drug, T-705, or favipiravir, was previously found to be effective against swine flu, or H1N1. Now Yoshihiro Kawaoka, a virologist at the university, has shown that the drug protects mice against bird flu, or H5N1.
Office of Strategic Communication